For the year ending 2025-12-31, AMP had $1,669M increase in cash & cash equivalents over the period. $8,161M in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total net revenues | 52 | 70 | 47 | 14 |
| Total benefits and expenses | 462 | 533 | 490 | 373 |
| Pretax loss before equity in earnings of subsidiaries | -410 | -463 | -443 | -359 |
| Effective tax rate | 205 | 182 | 142 | 139 |
| Loss before equity in earnings of subsidiaries | -615 | -645 | -585 | -498 |
| Equity in earnings of subsidiaries, net of tax | 4,178 | 4,046 | 3,141 | 3,057 |
| Net income | 3,563 | 3,401 | 2,556 | 2,559 |
| Depreciation, amortization and accretion, net | -93 | -159 | -154 | -40 |
| Deferred income tax expense (benefit) | 157 | 125 | 18 | -4 |
| Share-based compensation | 206 | 193 | 187 | 170 |
| Net realized investment (gains) losses | 3 | -15 | -47 | 1 |
| Net trading (gains) losses | 6 | 7 | 9 | -16 |
| Loss from equity method investments | -8 | -19 | -27 | -36 |
| Impairments and provision for loan and credit losses | 19 | 9 | -16 | 98 |
| Net (gains) losses of consolidated investment entities | -12 | 13 | -23 | -17 |
| Restricted and segregated investments | -477 | -102 | 8 | 96 |
| Deferred acquisition costs | -52 | -36 | -64 | -11 |
| Policyholder account balances, future policy benefits and claims, and market risk benefits, net | 4,610 | 3,831 | 3,071 | 1,433 |
| Derivatives, net of collateral | -394 | -1,696 | -624 | 315 |
| Receivables | 159 | -215 | -276 | -44 |
| Brokerage deposits | -385 | -55 | -781 | -345 |
| Accounts payable and accrued expenses | 261 | 105 | 354 | -219 |
| Current income tax, net | -108 | 200 | -387 | 116 |
| Deferred taxes, net | - | - | - | -4 |
| Other operating assets and liabilities of consolidated investment entities, net | -6 | -1 | 5 | -2 |
| Other, net | -100 | -273 | -46 | -291 |
| Net cash provided by (used in) operating activities | 8,323 | 6,595 | 4,685 | 4,407 |
| Proceeds from sales | 2,154 | 2,340 | 734 | 1,306 |
| Maturities, sinking fund payments and calls | 16,919 | 15,684 | 9,230 | 7,621 |
| Purchases | 19,504 | 18,536 | 19,694 | 22,034 |
| Proceeds from sales, maturities and repayments of mortgage loans | 240 | 175 | 152 | 169 |
| Funding of mortgage loans | 713 | 413 | 284 | 207 |
| Proceeds from sales, maturities and collections of other investments | 70 | 123 | 145 | 96 |
| Purchase of other investments | 51 | 158 | 116 | 99 |
| Purchase of investments by consolidated investment entities | 1,431 | 1,125 | 427 | 961 |
| Proceeds from sales, maturities and repayments of investments by consolidated investmententities | 988 | 1,117 | 643 | 615 |
| Purchase of land, buildings, equipment and software | 162 | 176 | 184 | 182 |
| Cash paid for written options with deferred premiums | 50 | 57 | 59 | 619 |
| Cash received from written options with deferred premiums | 20 | 22 | 43 | 204 |
| Cash returned (paid) for acquisition of business, net of cash acquired | - | 0 | 0 | -34 |
| Cash paid for deposit receivables | 29 | 33 | 39 | 45 |
| Cash received for deposit receivables | 427 | 592 | 774 | 550 |
| Other, net | 406 | 106 | 180 | 31 |
| Net cash provided by (used in) investing activities | -1,528 | -551 | -9,262 | -13,583 |
| Proceeds from additions | 3,064 | 4,942 | 11,193 | 8,343 |
| Maturities, withdrawals and cash surrenders | 6,123 | 7,212 | 7,039 | 4,339 |
| Deposits and other additions | 1,293 | 1,470 | 1,476 | 1,169 |
| Net transfers from (to) separate accounts | 163 | 176 | 132 | 162 |
| Surrenders and other benefits | 1,487 | 1,765 | 2,102 | 1,459 |
| Change in banking deposits, net | 1,356 | 809 | 3,193 | 6,885 |
| Cash paid for purchased options with deferred premiums | 121 | 148 | 53 | 197 |
| Cash received for purchased options with deferred premiums | 96 | 229 | 251 | 378 |
| Issuance of long-term debt, net of issuance costs | 741 | 0 | 1,335 | 495 |
| Repayments of long-term debt | 510 | 561 | 760 | 510 |
| Dividends paid to shareholders | 596 | 574 | 550 | 534 |
| Repurchase of common shares | 2,907 | 2,448 | 2,127 | 1,978 |
| Exercise of stock options | - | - | 0 | 0 |
| Borrowings of consolidated investment entities | 1,120 | 1,273 | 0 | 341 |
| Repayments of debt by consolidated investment entities | 922 | 1,004 | 275 | 4 |
| Other, net | 2 | 0 | 1 | 2 |
| Net cash provided by (used in) financing activities | -5,157 | -5,165 | 4,411 | 8,430 |
| Effect of exchange rate changes on cash | 31 | -10 | 31 | -68 |
| Net increase (decrease) in cash and cash equivalents, including amounts restricted | 1,669 | 869 | -135 | -814 |
| Cash and cash equivalents, including amounts restricted at beginning of period | 9,489 | - | - | 9,569 |
| Cash and cash equivalents, including amounts restricted at end of period | 11,158 | - | - | 8,755 |
AMERIPRISE FINANCIAL INC (AMP)
AMERIPRISE FINANCIAL INC (AMP)